Optics
← Today's headlines

3 sources checked · 2 source groups included · 4h ago

Still Watching

Astra Zeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

Fortune and Financial Times describe the same event in different terms.

1 Left2 Center0 Right
Still watching. Optics is waiting for a cleaner match before calling the split.

STILL WATCHING

As of August 2, 2026 at 11:59 PM, this is how Optics News reads the wording differences in this story.

What happened U.K. pharmaceutical giant Astra Zeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
The headline split The left frames it as "Astra Zeneca said to have explored Bristol Myers merger". The center frames it as "Astra Zeneca holds talks with Bristol Myers Squibb over $400bn tie-up".
Match confidence Medium confidence. 3 sources across 2 bias buckets. Useful framing signal — check the source list before sharing.
Same-event confidenceMedium

3 sources across 2 bias buckets agree on the event.

Framing confidenceModerate

54/99 — meaningful wording shift across the spectrum.

WHAT EACH SIDE EMPHASIZED

Left / center-leftAstra Zeneca said to have explored Bristol Myers merger

Fortune · Center-left · News report

CenterAstra Zeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

CNBC · Center · News report

Right / center-rightNo matching source in this bucket yet.

Optics keeps watching for pickup.

SEE THE HEADLINES

CenterMostly Factual
CNBCNews report · Aug 2, 10:17 PM

Astra Zeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

U.K. pharmaceutical giant Astra Zeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.

Open source
CenterHigh
Financial TimesNews report · Aug 2, 11:59 PM

Astra Zeneca holds talks with Bristol Myers Squibb over $400bn tie-up

Deal would create world’s fourth-largest drugmaker by market value

Open source
Center-leftHigh
FortuneNews report · Aug 2, 9:27 PM

Astra Zeneca said to have explored Bristol Myers merger

Bristol Myers Squibb, which has a $133 billion market capitalization, could provide Astra Zeneca with a bigger foothold in the US market.

Open source
Details54/99 Wording Gap · Medium confidence · 3 sources
54/99 Wording GapMedium confidence3 sources · 2 bias bucketsLive match · 3 sources · 2 buckets · comparable news formatFormats: News report

SOURCE MAP CHANGES

Aug 2, 9:27 PM: Fortune joined the source map.

Aug 2, 10:17 PM: CNBC joined the source map.

Aug 2, 11:59 PM: Financial Times joined the source map.

Now: Wording Gap is 54/99 and story health is live match · 3 sources · 2 buckets · comparable news format.